Yang-lin Liu

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆" [J Hepatol (2020) 505-515].

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆" [J Hepatol (2020) 505-515].

Journal: Journal of hepatology

Published: March 15, 2023

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515).

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515).

Journal: Journal of hepatology

Published: March 08, 2021

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆.

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆.

Journal: Journal of hepatology

Published: October 03, 2019

Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans.

Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans.

Journal: Aging

Published: June 15, 2016

TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?

TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?

Journal: Gastroenterology

Published: February 03, 2015

TM6SF2 as a genetic risk factor for fibrosis.

TM6SF2 as a genetic risk factor for fibrosis.

Journal: Hepatology (Baltimore, Md.)

Published: December 16, 2014

Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.

Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.

Journal: Journal of hepatology

Published: November 17, 2014

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Journal: Nature communications

Published: April 02, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026